FLC
ARIA

Francis L. Coolidge’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Francis L. Coolidge’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$306K Buy
+17,504
New +$310K 0.37% 94

Other funds holding ARIA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Francis L. Coolidge's ARIA Position: Q2 2013 in Review

Francis L. Coolidge opened a new position in Ariad Pharmaceuticals Inc (ARIA) in Q2 2013: 17,504 shares worth $306K. The stake represents 0.37% of the portfolio and ranks #94 among its holdings.

198 funds tracked by Wall St. Rank hold ARIA as of Q2 2013.

  • Francis L. Coolidge held 17,504 shares of Ariad Pharmaceuticals Inc worth $306K as of Q2 2013.
  • Ariad Pharmaceuticals Inc was a new Francis L. Coolidge position in Q2 2013.
  • Ariad Pharmaceuticals Inc made up 0.37% of Francis L. Coolidge's portfolio in Q2 2013, its #94 holding.
  • 198 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q2 2013.

Based on Francis L. Coolidge's 13F filing for Q2 2013, filed 7 Aug 2013.